Impact of Cervical Cancer Screening Education on Knowledge, Attitude, and Willingness to Uptake HPV Self-Sampling in Delta State

Download Article

DOI: 10.21522/TIJPH.2013.13.04.Art025

Authors : Priscilla Uruemuesiri EBUNU, Beatrice M. Ohaeri, Ezekiel Nwabuwanne EZEKIEL, Joel Ojo ALUKO

Abstract:

Cervical cancer remains a significant public health challenge in Nigeria, particularly among women of childbearing age. Despite available screening methods, the uptake of Human Papillomavirus Self-Sampling (HPVSS) remains low due to limited awareness and knowledge. This study evaluated the outcomes of a cervical cancer screening educational intervention on knowledge, attitude, and willingness to uptake HPVSS among childbearing women in Delta State, Nigeria. A quasi-experimental study was conducted using pre- and post-intervention assessments. A total of 196 questionnaires (98 each at pre- and post-intervention) were analyzed using SPSS version 25.0. The intervention involved structured educational sessions on cervical cancer screening and HPVSS. Descriptive statistics and paired-sample t-tests were used for data analysis. Post-intervention, awareness of HPVSS increased from 35.7% to 66.3%. The proportion of women with adequate knowledge improved from 6.1% to 45.9%. Positive attitude towards HPVSS risen from 99% to 100%, while willingness to uptake HPVSS improved from 93.9% to 99%. Significant differences were observed between pre- and post-intervention scores across all measured parameters (p < 0.000). The educational intervention significantly improved knowledge, attitude, and willingness to uptake HPVSS among childbearing women. These findings suggest that structured educational programs can enhance cervical cancer screening awareness and acceptance of HPVSS, potentially increasing screening uptake and reducing cervical cancer burden in Nigeria.

References:

[1].   Cao, W., Qin, K., Li, F., & Chen, W., 2024, Comparative study of cancer profiles between 2020 and 2022 using global cancer statistics (GLOBOCAN). Journal of the National Cancer Center4(2), 128-134.

[2].   Singh, D., Vignat, J., Lorenzoni, V., Eslahi, M., Ginsburg, O., Lauby-Secretan, B., ... & Vaccarella, S., 2023, Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. The lancet global health11(2), e197-e206.

[3].   World Health Organization, 2020, Global strategy to accelerate the elimination of cervical cancer as a public health problem. World Health Organization.

[4].   Lin, K., Hong, Q., Fu, Y., Tu, H., Lin, H., Huang, J., ... & Chen, M., 2024. Cervical HPV infection and related diseases among 149,559 women in Fujian: an epidemiological study from 2018 to 2023. Frontiers in Microbiology15, 1418218.

[5].   Arbyn, M., Costa, S., Latsuzbaia, A., Kellen, E., Girogi Rossi, P., Cocuzza, C. E., ... & Castle, P. E., 2023, HPV-based cervical cancer screening on self-samples in the Netherlands: challenges to reach women and test performance questions. Cancer Epidemiology, Biomarkers & Prevention32(2), 159-163.

[6].   Talabi, O., Gilbert, H., Fawzi, M. C. S., Anorlu, R., & Randall, T., 2023, Examining barriers and facilitators of HPV vaccination in Nigeria, in the context of an innovative delivery model: a mixed-methods study. BMJ Public Health1(1).

[7].   Amponsah-Dacosta, E., Kagina, B. M., & Olivier, J., 2020, Health systems constraints and facilitators of human papillomavirus immunization programmes in sub-Saharan Africa: a systematic review. Health policy and planning35(6), 701-717.

[8].   Oghenevwarhe, O. B., Soter, A., Adekunbiola, B., & Omosivie, M., Feasibility and Acceptability of Self-sampling for Human Papillomavirus DNA Testing Among Asymptomatic Women in Rural Delta State, Nigeria.

[9].   Dzobo, M., Dzinamarira, T., Maluleke, K., Jaya, Z. N., Kgarosi, K., & Mashamba-Thompson, T. P., 2023, Mapping evidence on the acceptability of human papillomavirus self-sampling for cervical cancer screening among women in sub-Saharan Africa: a scoping review. BMJ open13(4), e062090.

[10].  Maver, P. J., & Poljak, M., 2020, Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans. Clinical microbiology and infection26(5), 579-583.